S45 Following the Pathway Leads to Therapeutic Targets: Signals Regulating Pituitary Tumors

Program: Symposia
Basic/Translational Session
Sunday, April 3, 2016: 8:15 AM-9:45 AM
Room 205 (BCEC)
Sally A Camper, PhD, University of Michigan, Ann Arbor, MI

Nothing to Disclose: SAC
8:15 AM
Paul R. Le Tissier, PhD, Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
Nothing to Disclose: PRL
8:45 AM
Arthur Gutierrez-Hartmann, MD, Depts of Medicine and of Biochemistry & Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
Nothing to Disclose: AG
9:15 AM
Juan Pedro Martinez-Barbera, PhD, Developmental Biology and Cancer Programme, UCL Institute of Child Health, London, United Kingdom
Nothing to Disclose: JPM
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire